Drug Shortage Report for ACT EXEMESTANE

Last updated on 2019-03-14 History
Report ID 68592
Drug Identification Number 02390183
Brand name ACT EXEMESTANE
Common or Proper name EXEMESTANE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) EXEMESTANE
Strength(s) 25MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-01
Estimated end date 2019-02-15
Actual end date 2019-02-20
Shortage status Resolved
Updated date 2019-03-14
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-03-14 French Compare
v8 2019-03-14 English Compare
v7 2019-01-31 French Compare
v6 2019-01-31 English Compare
v5 2019-01-03 French Compare
v4 2019-01-03 English Compare
v3 2018-12-04 French Compare
v2 2018-12-04 English Compare
v1 2018-12-04 English Compare